Dana-Farber Cancer Institute - Oncology Department — Boston, Massachusetts

Dana-Farber Cancer Institute - Oncology Department is a clinical research site located in Boston, Massachusetts, United States 02215.

Crixeo Health Trust Score: 65/100 (FAIR). This profile has not yet been claimed by the site owner.

Dana-Farber Cancer Institute - Oncology Department has participated in 5 clinical trials with 4 currently active.

Therapeutic areas: Solid Tumors Harboring NTRK Fusion, Advanced Non-small Cell Lung Cancer, EGFR Mutation.

Sponsors: Bayer.

Sponsor Feasibility Report

Trust Score: 65/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Dana-Farber Cancer Institute - Oncology Department?

Dana-Farber Cancer Institute - Oncology Department has a Crixeo Trust Score of 65/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Dana-Farber Cancer Institute - Oncology Department conducted?

Dana-Farber Cancer Institute - Oncology Department has 5 clinical trials on record, with 4 currently active. Their work covers Solid Tumors Harboring NTRK Fusion, Advanced Non-small Cell Lung Cancer, EGFR Mutation.

Is Dana-Farber Cancer Institute - Oncology Department accredited by Crixeo Health?

Dana-Farber Cancer Institute - Oncology Department has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Dana-Farber Cancer Institute - Oncology Department?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.